CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analogue of Growth Hormone-
Releasing Hormone (GHRH), engineered to stimulate endogenous growth hormone (GH) secretion in a
sustained and physiologically rhythmic manner.
Unlike exogenous growth hormone, CJC-1295 + DAC does not replace GH.
Instead, it amplifies the body's own GH production, preserving natural feedback mechanisms and
pulsatile release patterns.
CJC-1295 (DAC 2 Mg)
CJC-1295 is a modified fragment of native GHRH, optimized for:
- High receptor affinity
- Resistance to enzymatic degradation
The defining feature is the Drug Affinity Complex (DAC).
What DAC Does
DAC enables the peptide to:- Bind reversibly to serum albumin
- Remain in circulation for extended periods
- Maintain prolonged biological activity
This modification extends the half-life from minutes (native GHRH) to several days, making CJC-1295
+ DAC a long-acting GH secretagogue.
















